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The demonstration that glucocorticoid-mediated activa-
tion can control occludin expression in brain capillary
endothelial cells has provided a new avenue of research in
the field of blood brain-barrier (BBB) permeability regula-
tion. In order to identify more key genes involved in glu-
cocorticoid-mediated regulation of BBB permeability, we
used cDNA microarrays to study changes in gene expres-
sion in dexamethasone-treated brain capillary endothelial
cEND cells: Primarily, we observed changes in expression
of the VE-cadherin gene involved in cell adhesion. Vascu-
lar-endothelial-cadherin (VE-cadherin) is an endothelial
cell-specific adhesion protein localized in cell-cell con-
tacts. It is known as an important determinant of vascular
architecture and endothelial cell survival. Quantitative
real-time PCR showed an upregulation of VE-cadherin
expression exclusively in cEND cells, in accordance to pre-
vious observations made for the occludin gene. Subse-
quently, we verified divergent transcriptional activation of
the VE-cadherin gene by dexamethasone. Furthermore, we
measured the change in protein levels of VE-cadherin and
demonstrated a transactivation of the VE-cadherin pro-
moter in cEND cells via dexamethasone. Dexamethasone
was further shown to induce cellular differentiation into a
cobblestone cellular morphology and reinforcement of
adherens junctions concomitant with the increased
anchorage of VE-cadherin to the actin cytoskeleton. We
thus propose that glucocorticoid effects on VE-cadherin
protein synthesis and organization are important for the
formation of both adherens and tight junction, and for
improved barrier properties in microvascular brain
endothelial cells.
To find cell- or tissue-specific ligands that could be used in
therapeutic regime of barrier disorder diseases it is neces-
sary to study and understand the molecular mechanisms
of beneficial effects of glucocorticoid action on BBB-genes
involved in BBB-permeability regulation.
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